Brendan Martin has been appointed general manager for the UK and Ireland at Genzyme.
Martin, who was previously deputy general manager for UK and Ireland, replaces Paul Drohan who is returning home to Canada.
The appointment will see Martin take on responsibility for all the company’s commercial activities in the region. These will mainly involve rare inherited diseases and immune conditions.
It is Martin’s most senior role at Genzyme, where he has spent ten years, joining its lysosomal storage disorders business in Ireland in 2002, before being promted to business unit director in 2007.
Robin Kenselaar, head of Genzyme EMEA, said: “Brendan’s appointment as general manager, UK and Ireland comes at a key time for the business as it builds its multiple sclerosis franchise and continues to develop in rare diseases.
“In his Genzyme career to date, Brendan has shown he is a leader with the experience, energy, vision and commitment to patients needed to move us forward.”